GlassScriptPhysician profile
Thomas T Wang
NPI 1629395967
$2,995.29
in general payments reported to CMS, 2019-2025
32 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $318 · 2021: $266 · 2022: $545 · 2023: $777 · 2024: $511 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,717.65 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $773.50 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip |
| Intuitive Surgical, INC. | $676.77 | 2020-2025 | Da Vinci Surgical System |
| Heron Therapeutics, INC. | $289.51 | 2022-2024 | Zynrelef |
| Tela Bio, INC. | $141.21 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biowound Solutions, INC. | $120.63 | 2024 | Bio-Connekt |
| Teleflex LLC | $119.30 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Philips North America LLC | $84.38 | 2025 | Azurion 5 M20 |
| Elucent Medical | $69.15 | 2022 | |
| Medtronic, INC. | $62.82 | 2023-2025 | Transorb, Ligasure, Signia |
| Lexington Medical, INC. | $61.11 | 2021 | |
| Cleerly, INC. | $58.03 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Osteoready LLC | $50.00 | 2019 | |
| Ethicon US, LLC | $43.23 | 2020-2023 | Enseal X1, Echelon Endopath, Echelon Flex |
| Aroa Biosurgery Incorporated | $39.20 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $38.61 | 2025 | Phasix Mesh |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $38.56 | 2019 | |
| Acera Surgical, INC. | $36.29 | 2025 | Restrata Wound Matrix |
| Endo Pharmaceuticals INC. | $31.11 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $30.55 | 2022 | |
| Biom'Up France Sas | $27.35 | 2021 | |
| Baxter Healthcare | $22.91 | 2023 | Peri-Strips Dry |
| Abbvie INC. | $22.78 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Solventum Corporation | $21.77 | 2025 | V.A.C.Ulta, Prevena |
| Endomagnetics LTD | $19.02 | 2024 | Magtrace, Magseed |
| Integra Lifesciences Corporation | $18.45 | 2022 | |
| Octapharma USA, INC. | $18.41 | 2025 | Fibryga |
| Tei Biosciences INC | $16.67 | 2019 | |
| Kerecis Limited | $14.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $13.49 | 2023 | Gattex |
| Reprise Biomedical, INC. | $12.13 | 2022 | |
| Covidien LP | $12.11 | 2020 | |
| Acell, INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.